Browse EX-10 agreements

Execution Version

Certain personally identifiable information has been omitted from this exhibit pursuant to

Item 601(a)(6) of Regulation S-K. [***] indicates that information has been redacted.

INTERCREDITOR AGREEMENT

THIS INTERCREDITOR AGREEMENT (this “Agreement”) is made as of the 27th day of May, 2026 (the “Effective Date”), by and among (a) Agile Capital Funding, LLC, a New York limited liability company, in its capacity as collateral agent (“Agile Collateral Agent”) and Agile Lending, LLC, a Virginia limited liability company (“Agile Lender”; and Agile Collateral Agent and Agile Lender herein collectively, “Agile Parties” and, each individually, an “Agile Party”), (b) Melar Acquisition Corp. I, a Cayman Islands exempted company (“Melar Acquisition”), and Melar Capital Group LLC, a New York limited liability company (“Melar Capital”) (collectively and individually, “Melar Lender”), and (c) YA II PN, Ltd., a Cayman Island exempt limited company (“YA Lender”); as acknowledged by Everli Global Inc.,

…

THE EXCHANGE CONTEMPLATED HEREIN IS INTENDED TO COMPORT WITH THE REQUIREMENTS OF SECTION 3(a)(9) OF THE SECURITIES ACT OF 1933, AS AMENDED.

EXCHANGE AGREEMENT

This Exchange Agreement (this “Agreement”) is entered into as of June 1, 2026 (the “Effective Date”) by and between Streeterville Capital, LLC, a Utah limited liablity company (“Lender”), and Jaguar Health, Inc., a Delaware corporation (“Borrower”). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Royalty Interest (as defined below).

A. Company previously sold and issued to Investor that certain Royalty Interest dated August 24, 2022 (the “Royalty Interest”) pursuant to that certain Royalty Interest Purchase Agreement dated August 24, 2022 (the “Purchase Agreement,” and together with the Royalty Interest and all other documents entered into in conjunction therewith, the “Transaction Documents”).

…

THE EXCHANGE CONTEMPLATED HEREIN IS INTENDED TO COMPORT WITH THE REQUIREMENTS OF SECTION 3(a)(9) OF THE SECURITIES ACT OF 1933, AS AMENDED.

EXCHANGE AGREEMENT

This Exchange Agreement (this “Agreement”) is entered into as of May 26, 2026 (the “Effective Date”) by and between Streeterville Capital, LLC, a Utah limited liablity company (“Lender”), and Jaguar Health, Inc., a Delaware corporation (“Borrower”). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Royalty Interest (as defined below).

A. Company previously sold and issued to Investor that certain Royalty Interest dated August 24, 2022 (the “Royalty Interest”) pursuant to that certain Royalty Interest Purchase Agreement dated August 24, 2022 (the “Purchase Agreement,” and together with the Royalty Interest and all other documents entered into in conjunction therewith, the “Transaction Documents”).

…

Execution Version

CREDIT AGREEMENT

dated as of May 29, 2026

among

FLEX LTD.,

as the Borrower,

CITIBANK, N.A.,

as the Administrative Agent,

and

The Lenders Party Hereto

and

CITIBANK, N.A.,

BOFA SECURITIES, INC.,

BANCO BILBAO VIZCAYA ARGENTARIA, S.A. NEW YORK BRANCH,

BANK OF CHINA, NEW YORK BRANCH,

BNP PARIBAS SECURITIES INC.,

CHINA CONSTRUCTION BANK, NEW YORK BRANCH,

DBS BANK LTD.,

INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED, NEW YORK BRANCH,

MIZUHO BANK, LTD.,

MUFG BANK, LTD.,

PNC BANK, NATIONAL ASSOCIATION,

THE BANK OF NOVA SCOTIA,

U.S. BANK NATIONAL ASSOCIATION

and

UNICREDIT BANK GMBH

as Joint Lead Arrangers and Joint Bookrunners

and

BANK OF AMERICA, N.A., as Syndication Agent

and

BANCO BILBAO VIZCAYA ARGENTARIA, S.A. NEW YORK BRANCH,

BANK OF CHINA, NEW YORK BRANCH,

BNP PARIBAS,

CHINA CONSTRUCTION BANK, NEW YORK BRANCH,

DBS BANK LTD.,

INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED, NEW YORK BRANCH,

MIZUHO BANK, LTD.,

…

Fiscal 2026 Executive Incentive Plan. On June 1, 2026, the Compensation Committee (the “Committee”) of the Board of Directors (the "Board") of American Superconductor Corporation (the “Company”) and the Board approved an executive incentive plan for the Company’s fiscal year ending March 31, 2027 (“fiscal 2026”). Participants in the plan include the Company’s chief executive officer and all other current executive officers. Pursuant to the plan, each participant is designated a target cash incentive amount, expressed as a percentage of the participant’s annual base salary. The Committee is responsible for determining the payout under the plan to each participant except the chief executive officer. The Board determines the payout under the plan for the chief executive officer, taking into account the recommendation of the Committee.

…

*PUBLISHED CUSIP NUMBERS:

DEAL: 48917MAL6

TERM LOAN FACILITY: 48917MAM4

$500,000,000

TERM LOAN CREDIT AGREEMENT

among

KENNAMETAL INC.,

as Borrower

The Several Lenders From Time To Time Parties Hereto,

PNC BANK, NATIONAL ASSOCIATION,

and

U.S. BANK NATIONAL ASSOCIATION,

as the Co-Syndication Agents,

and

BANK OF AMERICA, N.A.,

as the Administrative Agent

Dated as of May 28, 2026

BOFA SECURITIES, INC.,

PNC CAPITAL MARKETS LLC,

and

U.S. BANK NATIONAL ASSOCIATION,

as Joint Book Runners and as Joint Lead Arrangers

---

TABLE OF CONTENTS

…

FIRST AMENDMENT TO SEVENTH AMENDED AND RESTATED CREDIT AGREEMENT AND

COMMITMENT INCREASE AMENDMENT

dated as of May 28, 2026

among

KENNAMETAL INC.

and

KENNAMETAL EUROPE GmbH,

as Borrowers,

THE INCREASE LENDERS PARTY HERETO,

THE OTHER LENDERS AND THE ISSUING LENDERS PARTY HERETO,

BANK OF AMERICA, N.A., LONDON BRANCH,

as Euro Swingline Lender,

and

BANK OF AMERICA, N.A.,

as the Administrative Agent

PNC BANK, NATIONAL ASSOCIATION,

BNP PARIBAS and

U.S. BANK NATIONAL ASSOCIATION,

as the Co-Syndication Agents,

CITIZENS BANK, N.A.,

as the Documentation Agent

BOFA SECURITIES, INC.,

PNC CAPITAL MARKETS LLC,

BNP PARIBAS and

U.S. BANK NATIONAL ASSOCIATION,

as Joint Book Runners and as Joint Lead Arrangers

---

FIRST AMENDMENT TO SEVENTH AMENDED AND RESTATED CREDIT AGREEMENT AND COMMITMENT INCREASE AMENDMENT

…

ROMAN DBDR ACQUISITION CORP. II

9858 Clint Moore Road, Suite 205

Boca Raton, FL 33496

May 27, 2026

John J. Birmingham 6815 E. Camelback Road, Apt 6010

Scottsdale, AZ 85251

Re: CFO Offer Addendum

Dear Mr. Birmingham,

Roman DBDR Acquisition Corp. II, a Cayman Islands exempted company (the “Company”), is pleased to extend your position as Chief Financial Officer and Principal Financial and Accounting Officer (“CFO”). This extension agreement (the “Agreement”) shall constitute an agreement between you and the Company and contains all the terms and conditions relating to the services you agree to provide to the Company.

1. Term. Your term (the “Term”) as the CFO shall remain in effective as of the date of this Agreement (the “Effective Date”) and shall end as of the earlier of the date: (i) either party terminates this Agreement pursuant to written notice to the other party; (ii) the date that the Company’s initial business combination is consummated; (iii) the date the Company is wound up; or (iv) the date that you vacate or are removed from your position.

…

CNL Strategic Capital, LLC 8-K

Exhibit 10.1

Date: as of May 29, 2026

CNL Strategic Capital B, Inc. CNL Strategic Capital, LLC 450 South Orange Avenue Orlando, FL 32801 Attention: Tammy Tipton

Re:       Third Amendment to Loan and Security Agreement

Ladies and Gentlemen:

We refer to that certain Loan and Security Agreement by and among, CNL Strategic Capital B, Inc., a Delaware Corporation (“Borrower”) and CNL Strategic Capital, LLC, a Delaware limited liability company (“Guarantor” together with Borrower, individually and collectively, as the context requires, but in each case jointly and severally, “Obligor” or “you”) and Valley National Bank (“Bank”, “we” or “us”) dated February 15, 2024 (as amended, restated, supplemented or otherwise modified, the “Loan Agreement”). Unless otherwise defined in this amendment letter (the “Amendment”), capitalized terms are used as defined in the Loan Agreement.

…

Appendix A

HARVARD BIOSCIENCE, INC.

EMPLOYEE STOCK PURCHASE PLAN

(As Amended)

The purpose of the Harvard Bioscience, Inc. Employee Stock Purchase Plan (the “Plan”) is to provide eligible employees of Harvard Bioscience, Inc. (the “Company”) and certain of its subsidiaries with opportunities to purchase shares of the Company’s common stock, par value $.01 per share (the “Common Stock”). Three Hundred Ten Thousand (310,000) One Million Nine Hundred Thousand (190,000) shares of Common Stock in the aggregate have been approved and reserved for this purpose. The Plan is intended to constitute an “employee stock purchase plan” within the meaning of Section 423(b) of the Internal Revenue Code of 1986, as amended (the “Code”), and shall be interpreted in accordance with that intent.

…

FORTE BIOSCIENCES, INC.

AMENDED AND RESTATED 2021 EQUITY INCENTIVE PLAN

(Adopted and Approved Effective April 28, 2026)

1. Purposes of the Plan. The purposes of this Plan are:

	•		to attract and retain the best available personnel for positions of substantial responsibility,

	•		to provide additional incentive to Employees, Directors and Consultants, and

	•		to promote the success of the Company’s business.

The Plan permits the grant of Incentive Stock Options, Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units and Performance Awards.

2. Definitions. As used herein, the following definitions will apply:

2.1 “Administrator” means the Board or any of its Committees as will be administering the Plan, in accordance with Section 4 of the Plan.

…

THE GOGO INC. AMENDED AND RESTATED 2024 OMNIBUS EQUITY INCENTIVE PLAN

The Gogo Inc. 2024 Omnibus Equity Incentive Plan (“2024 Plan) was originally adopted by the Board and approved by the shareholders of the Company. The Board has approved this amendment and restatement of the 2024 Plan (as so amended and restated, the “Plan”) to, among other things, increase the aggregate number of shares of Stock available for issuance under the Plan, subject to approval by the shareholders of the Company. This amendment and restatement shall be effective upon the date on which it is approved by the shareholders of the Company in accordance with Section 14 hereof.

Section 1.

PURPOSE

…